The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
An overview of FDA-approved biologics medicines
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Replacing the complementarity-determining regions in a human antibody with those from a mouse
Jones, P. T., Dear, P. H., Foote, J., Neuberger, M. S., & Winter, G. (1986) · Nature · doi:10.1038/321522a0 · Cited by 1,406
An overview of FDA-approved new molecular entities: 1827–2013
Kinch, M. S., Haynesworth, A., Kinch, S. L., & Hoyer, D. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.03.018 · Cited by 210
Self-citation
Cited by
An analysis of FDA-approved drugs: natural products and their derivatives
Patridge, E., Gareiss, P., Kinch, M. S., & Hoyer, D. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.01.009 · Cited by 831
Self-citationGlobal trends of pulmonary infections with nontuberculous mycobacteria: a systematic review
Dahl, V. N., Mølhave, M., Fløe, A., van Ingen, J., Schön, T., Lillebaek, T., Andersen, A. B., & Wejse, C. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.10.013 · Cited by 329
Applications, challenges, and needs for employing synthetic biology beyond the lab
Brooks, S. M., & Alper, H. S. (2021) · Nature Communications · doi:10.1038/s41467-021-21740-0 · Cited by 286
Aykul, S., & Martinez-Hackert, E. (2016) · Analytical Biochemistry · doi:10.1016/j.ab.2016.06.025 · Cited by 284
Of leaders and laggards - Towards digitalization of the process industries
Aaldering, L. J., & Song, C. H. (2021) · Technovation · doi:10.1016/j.technovation.2020.102211 · Cited by 66
Metadata
- Authors
- Kinch, M. S.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2015-04
- Volume
- 20
- Issue
- 4
- Pages
- 393-398
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2067355824
- Cited by
- 164
- References
- 2
- FWCI
- 4.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An overview of FDA-approved biologics medicines. https://app.cochat.ai/papers/10.1016/j.drudis.2014.09.003
- The paper
- Kinch, M. S. (2015). An overview of FDA-approved biologics medicines. Drug Discovery Today. https://doi.org/10.1016/j.drudis.2014.09.003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.